Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months

被引：0

作者：

Byrne, Robert A. ^{[3
,4
,10
]}

Valgimigli, Marco ^{[4
,11
,12
]}

Bhatt, Deepak L. ^{[13
]}

Coughlan, J. J. ^{[3
]}

Gibson, C. Michael ^{[14
]}

Rossello, Xavier ^{[5
,6
,7
,8
]}

Gorog, Diana A. ^{[15
]}

Ibanez, Borja ^{[7
,8
,9
]}

James, Stefan ^{[16
]}

Landi, Antonio ^{[10
,11
]}

Steg, P. Gabriel ^{[17
]}

Stone, Gregg W. ^{[18
]}

Andreotti, Felicita ^{[1
,2
]}

机构：

[1] Fdn Policlin Univ Gemelli IRCCS, Cardiovasc Sci Dept, Largo Gemelli 8, I-00168 Rome, Italy

[2] Catholic Univ, Med Sch, CardioThorac Dept, Rome, Italy

[3] Cardiovasc Res Inst, Mater Private Network, 73 Eccles St, Dublin D07 WKW8, Ireland

[4] RCSI Univ Med & Hlth Sci, Sch Pharm & Biomol Sci, Dublin, Ireland

[5] Hosp Univ Son Espases, Cardioctr Ticino Inst, CH-6900 Palma, Switzerland

[6] Univ Italian Switzerland, Fac Biomed Sci, Palma, Switzerland

[7] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain

[8] CIBERCV, Madrid, Spain

[9] IIS Fdn Jimenez Diaz, Dept Cardiol, Madrid, Spain

[10] Ente Osped Cantonale EOC, Cardioctr Ticino Inst, CH-6900 Lugano, Switzerland

[11] Univ Italian Switzerland, Fac Biomed Sci, Lugano, Switzerland

[12] Univ Bern, Bern, Switzerland

[13] Mt Sinai Fuster Heart Hosp, Icahn Sch Med Mt Sinai, New York, NY USA

[14] Harvard Med Sch, Boston, MA USA

[15] Imperial Coll, Natl Heart & Lung Inst, Fac Med, London, England

[16] Uppsala Univ, Uppsala Clin Res Ctr, Dept Med Sci, Uppsala, Sweden

[17] Paris Cite Univ, Bichat Hosp, AP HP, Paris, France

[18] Zena & Michael A Wiener Cardiovasc Inst, Icahn Sch Med Mt Sinai, New York, NY USA

来源：

EUROPEAN HEART JOURNAL | 2025年

关键词：

Acute coronary syndrome; Antithrombotic therapy; Dual antiplatelet therapy; Duration; ANTITHROMBOTIC THERAPY; CLOPIDOGREL; TICAGRELOR; IMPLANTATION; STRATEGIES; PRASUGREL; OUTCOMES;

D O I：

10.1093/eurheartj/ehaf070

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：14

共 50 条

[31] Dual antiplatelet therapy after percutaneous coronary intervention for stable CAD or ACS Redefining the optimal duration of treatment
Staehli, B. E.
Landmesser, U.
HERZ, 2018, 43 (01) : 11 - 19
[32] Antiplatelet Therapy and Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome and Thrombocytopenia
Yusuf, Syed Wamique
Iliescu, Cezar
Bathina, Jaya D.
Daher, Iyad N.
Durand, Jean-Bernard
TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (03) : 336 - 340
[33] Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome
Varenhorst, Christoph
Jensevik, Karin
Jernberg, Tomas
Sundstrom, Anders
Hasvold, Pal
Held, Claes
Lagerqvist, Bo
James, Stefan
EUROPEAN HEART JOURNAL, 2014, 35 (15) : 969 - +
[34] Dual antiplatelet therapy in patients with an acute coronary syndrome: up to 12 months and beyond
Pareek, Manan
Bhatt, Deepak L.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2018, 20 (0B) : B21 - B28
[35] Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a GReek AntiPlatElet registry substudy
Hamilos, Michalis
Petousis, Stylianos
Xanthopoulou, Ioanna
Goudevenos, John
Kanakakis, John
Sitafidis, George
Vavouranakis, Manolis
Skalidis, Emmanuel
Kochiadakis, George
Lekakis, John
Vardas, Panos E.
Alexopoulos, Dimitrios
CORONARY ARTERY DISEASE, 2018, 29 (01) : 53 - 59
[36] Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention
Roffman, David S.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S18 - S24
[37] TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION
Hubin
Zhouyujie
Liuyuyang
Shidongmei
Zhaoyingxin
Jiadean
HEART, 2011, 97
[38] Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Insights From a Network Meta-Analysis of Randomized Trials
Kuno, Toshiki
Ueyama, Hiroki
Takagi, Hisato
Fox, John
Bangalore, Sripal
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B109 - B110
[39] Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Insights From a Network Meta-Analysis of Randomized Trials
Kuno, Toshiki
Ueyama, Hiroki
Takagi, Hisato
Fox, John
Bangalore, Sripal
CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2021, 28 : 50 - 56
[40] MULTIFACTORIAL PROGNOSTICATION OF THE DEVELOPMENT OF STENT THROMBOSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER PERCUTANEOUS CORONARY INTERVENTION ON THE BACKGROUND OF DUAL ANTIPLATELET THERAPY
Korotaeva, E. S.
Koroleva, L. Y.
Nosov, V. P.
Kovaleva, G., V
Kuzmenko, E. A.
KARDIOLOGIYA, 2019, 59 (11) : 5 - 13

← 1 2 3 4 5 →